LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 326

Search options

  1. Article: Das Lungenzellkarzinom des Nichtrauchers. Martin Sebastian, Berthold Fischer, Roland Buhl, III. Medizinische Klinik der Johannes-Gutenberg-Universität Mainz, Schwerpunkt Pneumologie

    Sebastian, Martin / Fischer, Berthold / Buhl, Roland

    Journal Onkologie

    2008  Volume 8, Issue 7/8, Page(s) 349–352

    Language German
    Document type Article
    ZDB-ID 2108287-X
    ISSN 1618-7687
    Database Current Contents Medicine

    More links

    Kategorien

  2. Article ; Online: As-needed ICS/formoterol or as-needed SABA in mild asthma?

    Krishnan, Jerry A / Buhl, Roland

    The European respiratory journal

    2024  Volume 63, Issue 4

    MeSH term(s) Humans ; Formoterol Fumarate/therapeutic use ; Asthma/drug therapy ; Budesonide
    Chemical Substances Formoterol Fumarate (W34SHF8J2K) ; Budesonide (51333-22-3)
    Language English
    Publishing date 2024-04-04
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.02308-2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Treatment of small airway diseases

    Buhl, Roland

    today and tomorrow

    (Pneumologie ; 63, Suppl. 2)

    2009  

    Author's details Gasthrsg. R. Buhl
    Series title Pneumologie ; 63, Suppl. 2
    Collection
    Language German ; English
    Size S. S95 - S116 : Ill., graph. Darst.
    Publisher Thieme
    Publishing place Stuttgart
    Publishing country Germany
    Document type Article
    HBZ-ID HT016189554
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  4. Article ; Online: Die neue fachärztliche Asthma-Leitlinie 2023: Wegbegleiter und Meilenstein in der Asthma-Versorgung.

    Lommatzsch, Marek / Buhl, Roland

    Pneumologie (Stuttgart, Germany)

    2023  Volume 77, Issue 8, Page(s) 459–460

    Title translation The new asthma guidelines for respiratory specialists 2023: companion and milestone in asthma care.
    Language German
    Publishing date 2023-08-24
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 607630-0
    ISSN 1438-8790 ; 0934-8387
    ISSN (online) 1438-8790
    ISSN 0934-8387
    DOI 10.1055/a-2122-8941
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Die neue fachärztliche Asthma-Leitlinie 2023: Wegbegleiter und Meilenstein in der Asthma-Versorgung

    Lommatzsch, Marek / Buhl, Roland

    Pneumologie

    2023  Volume 77, Issue 08, Page(s) 459–460

    Language German
    Publishing date 2023-08-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 607630-0
    ISSN 1438-8790 ; 0934-8387
    ISSN (online) 1438-8790
    ISSN 0934-8387
    DOI 10.1055/a-2122-8941
    Database Thieme publisher's database

    More links

    Kategorien

  6. Article: Schweres und schwer zu behandelndes Asthma bronchiale - Definition, Diagnose und Update der Therapieoptionen

    Buhl, Roland

    Arzt & Praxis

    2018  Volume 72, Issue 8, Page(s) 29

    Language German
    Document type Article
    ZDB-ID 1224197-0
    ISSN 0048-5128
    Database Current Contents Medicine

    More links

    Kategorien

  7. Article ; Online: Reply to the Letter Entitled "FeNO Variability when Using Different Analyzers at the Joint ATS/ERS Guideline Cutoff".

    Korn, Stephanie / Buhl, Roland

    Respiration; international review of thoracic diseases

    2019  Volume 99, Issue 1, Page(s) 94

    MeSH term(s) Breath Tests ; Exhalation ; Nitric Oxide
    Chemical Substances Nitric Oxide (31C4KY9ESH)
    Language English
    Publishing date 2019-12-11
    Publishing country Switzerland
    Document type Letter ; Comment
    ZDB-ID 206674-9
    ISSN 1423-0356 ; 0025-7931
    ISSN (online) 1423-0356
    ISSN 0025-7931
    DOI 10.1159/000504631
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study.

    Galata, Christian / Schiller, Philipp / Müller, Lukas / Karampinis, Ioannis / Stamenovic, Davor / Buhl, Roland / Kreuter, Michael / Roessner, Eric Dominic

    Thoracic cancer

    2024  

    Abstract: Background: This study investigated the role of the thoracic skeletal muscle mass as a marker of sarcopenia on postoperative mortality in pleural empyema.: Methods: All consecutive patients (n = 103) undergoing surgery for pleural empyema in a single ...

    Abstract Background: This study investigated the role of the thoracic skeletal muscle mass as a marker of sarcopenia on postoperative mortality in pleural empyema.
    Methods: All consecutive patients (n = 103) undergoing surgery for pleural empyema in a single tertiary referral center between January 2020 and December 2022 were eligible for this study. Thoracic skeletal muscle mass index (TSMI) was determined from preoperative computed tomography scans. The impact of TSMI and other potential risk factors on postoperative in-hospital mortality was retrospectively analyzed.
    Results: A total of 97 patients were included in this study. The in-hospital mortality rate was 13.4%. In univariable analysis, low values for preoperative TSMI (p = 0.020), low preoperative levels of thrombocytes (p = 0.027) and total serum protein (p = 0.046) and higher preoperative American Society of Anesthesiologists (ASA) category (p = 0.007) were statistically significant risk factors for mortality. In multivariable analysis, only TSMI (p = 0.038, OR 0.933, 95% CI: 0.875-0.996) and low thrombocytes (p = 0.031, OR 0.944, 95% CI: 0.988-0.999) remained independent prognostic factors for mortality.
    Conclusions: TSMI was a significant prognostic risk factor for postoperative mortality in patients with pleural empyema. TSMI may be suitable for risk stratification in this disease with high morbidity and mortality, which may have further implications for the selection of the best treatment strategy.
    Language English
    Publishing date 2024-04-10
    Publishing country Singapore
    Document type Journal Article
    ZDB-ID 2625856-0
    ISSN 1759-7714 ; 1759-7706
    ISSN (online) 1759-7714
    ISSN 1759-7706
    DOI 10.1111/1759-7714.15307
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Future perspectives of anticholinergics for the treatment of asthma in adults and children.

    Buhl, Roland / Hamelmann, Eckard

    Therapeutics and clinical risk management

    2019  Volume 15, Page(s) 473–485

    Abstract: Despite major advances in therapeutic interventions and the availability of detailed treatment guidelines, a high proportion of patients with symptomatic asthma remain uncontrolled. Asthma management is largely guided by the Global Initiative for Asthma ( ...

    Abstract Despite major advances in therapeutic interventions and the availability of detailed treatment guidelines, a high proportion of patients with symptomatic asthma remain uncontrolled. Asthma management is largely guided by the Global Initiative for Asthma (GINA) strategy and is based on a backbone of inhaled corticosteroid (ICS) therapy with the use of additional therapies to achieve disease control. Inhaled long-acting bronchodilators alone and in combination are the preferred add-on treatment options. Although long-acting muscarinic antagonists (LAMAs) are a relatively recent addition to disease management recommendations for asthma, tiotropium has been extensively studied in a large clinical trial program. In Europe and the United States, tiotropium is approved for patients aged ≥6 years and uncontrolled on medium- to high-dose ICS/long-acting β
    Language English
    Publishing date 2019-03-14
    Publishing country New Zealand
    Document type Journal Article ; Review
    ZDB-ID 2186560-7
    ISSN 1178-203X ; 1176-6336
    ISSN (online) 1178-203X
    ISSN 1176-6336
    DOI 10.2147/TCRM.S180890
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort.

    Hinze, Christopher Alexander / Ehmann, Rainer / Jandl, Margret / Milger, Katrin / Schmidt, Olaf / Schulz, Christian / Skowasch, Dirk / Welte, Tobias / Buhl, Roland / Hamelmann, Eckard / Idzko, Marco / Taube, Christian / Korn, Stephanie / Suhling, Hendrik

    ERJ open research

    2024  Volume 10, Issue 2

    Abstract: After the GINA update in 2019, the proportion of SMART therapy increased with evidence for better disease control in SMART patients compared to SABA ... ...

    Abstract After the GINA update in 2019, the proportion of SMART therapy increased with evidence for better disease control in SMART patients compared to SABA alone
    Language English
    Publishing date 2024-04-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 2827830-6
    ISSN 2312-0541
    ISSN 2312-0541
    DOI 10.1183/23120541.00741-2023
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top